Biological E. Limited has appointed Anumeha Srivastava as Chief Executive Officer of its Digital Health Joint Venture, entrusting her with the responsibility of driving the company’s digital healthcare strategy and accelerating innovation in the rapidly evolving health technology landscape. In her new role, she will focus on advancing digital health initiatives, expanding strategic partnerships, and strengthening the organization’s position in technology-enabled healthcare.
Anumeha joins Biological E. after a distinguished career at Qure.ai, where she most recently served as Chief Business Officer. During her tenure, she played a significant role in scaling the company’s global business operations and commercial strategy. She also held several leadership positions, including Chief Customer Officer, Vice President – Head of Client Success, and Vice President – Client Success & Operations. Across these roles, she helped expand the adoption of AI-powered healthcare solutions while leading customer success initiatives across key international markets, including the United Kingdom, Europe, Asia-Pacific, and the Middle East.
Before joining Qure.ai, Anumeha gained extensive experience across healthcare delivery, operations, and social impact. She worked in Product and Operations at Max Healthcare, where she contributed to healthcare service development and operational excellence. She also led healthcare and inclusion programs at The Ganga Trust, focusing on community-driven initiatives. Earlier in her career, she served as a medical professional at Christian Medical College Vellore, where her work included patient care, rehabilitation services, community health outreach, and clinical research.
With a unique blend of clinical expertise, operational leadership, and digital healthcare experience, Anumeha is well positioned to lead Biological E.’s digital health venture and support its long-term vision of transforming healthcare through innovation and technology.
